Clinical Trial Update: A Study of the Safety and Efficacy of Infliximab(REMICADE ) in Pediatric Patients With Moderately to SeverelyActive Ulcerative Colitis [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the safety and efficacy of infliximab (Remicade) in pediatric patients with moderately to severely active ulcerative colitis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Remicade (infliximab)

Snippet

Sponsor: Centocor, Inc. | Conditions: Ulcerative Colitis | Phase 3 | Status: COMPLETED | Results posted: 2011-08-10